scispace - formally typeset
A

Allen P. Kaplan

Researcher at Medical University of South Carolina

Publications -  93
Citations -  8956

Allen P. Kaplan is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Histamine & Immunoglobulin E. The author has an hindex of 42, co-authored 93 publications receiving 8381 citations. Previous affiliations of Allen P. Kaplan include Walter Reed Army Medical Center & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

TL;DR: This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms, and outlines evidence-based diagnostic and therapeutic approaches for the different subtypes ofUrticaria.
Journal ArticleDOI

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

Torsten Zuberbier, +48 more
- 01 Jul 2018 - 
TL;DR: In this paper, an evidence-and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group.
Journal ArticleDOI

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

TL;DR: Omalizumab diminished clinical symptoms and signs of chronic idiopathic urticaria in patients who had remained symptomatic despite the use of approved doses of H-antihistamine therapy (licensed doses).
Journal ArticleDOI

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

TL;DR: In this paper, the authors evaluated the safety and efficacy of 24 weeks of treatment with omalizumab in patients with persistent chronic idiopathic urticaria/chronic spontaneous urticria (CIU/CSU) despite treatment with H 1 -antihistamines at up to 4 times the approved dose plus H 2 -antiHistamines, leukotriene receptor antagonists, or both.
Book Chapter

Urticaria and Angioedema

TL;DR: The histopathological features of urticaria are dilatation of cutaneous blood vessels and lymphatics in the superficial dermis, widening of dermal papillae, flattening of rete pegs, and swelling of collagen fibers.